TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 DKK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 732,832 | 701,850 | 718,237 |
Earnings before taxes | 22,308 | 16,838 | 29,547 |
Total assets | 354,474 | 378,443 | 351,751 |
Current assets | 354,254 | 347,014 | 318,031 |
Current liabilities | 208,001 | 237,076 | 190,697 |
Equity capital | 143,487 | 127,234 | 159,934 |
- share capital | 4,000 | 4,000 | 4,000 |
Employees (average) | 150 | 150 | 150 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 40.5% | 33.6% | 45.5% |
Turnover per employee | 4,886 | 4,679 | 4,788 |
Profit as a percentage of turnover | 3.0% | 2.4% | 4.1% |
Return on assets (ROA) | |||
Current ratio | 170.3% | 146.4% | 166.8% |
Return on equity (ROE) | 15.5% | 13.2% | 18.5% |
Change turnover | 30,982 | -16,387 | -89,917 |
Change turnover % | 4% | -2% | -11% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.